Short Sellers Look Scared of Big Biotech
The short interest data are out for the January 30 settlement date. 24/7 Wall St. has reviewed the top biotech companies, without focusing on speculative companies.
The short interest data are out for the January 30 settlement date. 24/7 Wall St. has reviewed the top biotech companies, without focusing on speculative companies.
Credit Suisse downgraded Gilead Sciences to Neutral and lowered its price target, citing increased competition for hepatitis C drugs.
Friday's top analyst upgrades, downgrades and initiations include Best Buy, Gilead Sciences, KeyCorp, National Bank of Greece, Pandora Media, Staples and Yelp.
Gilead Sciences has become so large and accumulated enough capital that it has decided to begin paying a dividend, a move follows Amgen.
Gilead Sciences reported better-than-expected fourth-quarter results Tuesday after the markets closed.
Tuesday after the U.S. markets close, Gilead Sciences will report its fourth-quarter financial results.
24/7 Wall St. has put together a preview of some of the larger companies reporting quarterly results in the coming week.
24/7 Wall St. has reviewed the top biotech companies, without focusing on speculative companies. For the majority of the selected stocks, short interest is down.
Merck shares posted a new 52-week high last Tuesday and closed Friday less than a buck from that high. Year to date, Its shares are up 11%.
24/7 Wall St. has reviewed the short interest in the top biotech companies, without focusing on speculative companies.
Gilead Sciences was picked up by Anthem to provide its hepatitis C drug as the primary option for patients.
ThinkstockLooking back at 2014, biotechs had a phenomenal year, and this looks to continue into 2015. The NYSE Arca Biotech index was up over 45% for 2014, and Wells Fargo expects that…
A new research report from the analysts at Cowen highlights the firm's top health care picks, many of which have some huge upside potential to the posted price targets.
Tuesday's top analyst upgrades, downgrades and initiations seen from Wall Street research calls include GE, Gilead Sciences, Oracle, Under Armour and El Pollo Loco.
Is it possible that Gilead Sciences is already coming back into favor after just a week of being in the doghouse?